Get In Touch
The global follow-on biologics market is gaining momentum as a response to the expiry of a number of patents on key biologicals and growing consumer demand for cost-effective biologicals treatment. Even though Europe has led the regulatory process for enhancing the availability of follow-on biologics, approvals in the U.S. for biologicals have lagged behind those in the international community.
 
The research report maps all the crucial aspects of the biologicals in oncology market. It covers market projections, prominent industry trends, and market drivers and restraints of biologicals. In addition, the report provides a snapshot of the research and development activities in the biologicals in oncology market. These R&D projects will influence the biologicals markets significantly and will set the pace of the market during the forecast period of 2013 to 2019.
 
Overview of the global biologicals in oncology market
 
The global biological drugs market is estimated to be worth US$287,139.7 million by the end of 2020. North America leads the biologicals in oncology market, followed by Europe and Asia Pacific. The primary driver of the biologicals in oncology market is increasing government support to improve healthcare conditions. Among the registered therapies of biologicals in oncology, vaccine therapy, and monoclonal antibodies therapy generate the major chunk of revenue, as they increase the chances of uptake of cancerous tissue.
 
Biologicals to treat cancer involve bacteria or vaccines which stimulate the body’s defense response against cancer cells. The biologicals in oncology industry is segmented according to the type of biological, development state, and pathway mapping used for cancer therapy investigation. In the coming years, the biologicals in oncology market will experience rapid growth as the prevalence of the cancer accelerates worldwide.
 
However, the major inhibitor for the market is the fear of side effects of the biological drugs treatment. According to cancer.gov, the side effects associated with various biological therapies can differ according to the treatment types. Some of these include pain, swelling, redness, soreness, itchiness, and rashes at the site of injection.
 
Companies mentioned in the research report 
 
Over 880 enterprises with their partners are involved in developing approximately 1,500 drugs in research and development projects to treat 132 cancer types. Some of the companies and institutes that are involved in clinical trials and manufacturing of biologicals are F. Hoffmann – La Roche, Limited, Astex Therapeutics, Prometheus Therapeutics and Diagnostics, Merck and Company, Northwest Biotherapeutics, Immunovative Therapies, The University of Bologna Medical School, NewLink Genetics Corporations, Rui Jin Hospital, National Institute of Mental Health, Hadassah University Hospital, and Peking University People’s Hospital.
 
Major types of biologicals available in market are:
  • Monoclonal antibodies
  • Vaccine therapy
  • Cytokine therapy
  • Oncolytic virus therapy
  • Adoptive T-cell therapy
  • DNA oligonucleotide therapy
  • Gene therapy
  • RNA oligonucleotide therapy
According to development stage of drugs, the market is segmented as:
  • Marketed 
  • Pre-registration
  • Registered 
  • Phase I clinical trials
  • Phase II clinical trials
  • Phase III clinical trials
  • No Data
  • Preclinical trials
  • Ceased
  • Suspended
Based on pathways involved in cancer therapy investigation, the market is segmented as:
  • BioCarta pathways
  • NetPath pathways
  • NCI-Nature pathways
  • KEGG pathways

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Biologicals Oncology Market